Smith & Nephew plc

NYSE:SNN

Medical - Devices

Healthcare
$30.32 -1.39%

-$0.43 today

Market cap
$12.72B
Beta
0.67
P/E (TTM)
20.1
EPS (TTM)
$0.74
Dividend yield
2.59%
52W Low $28.79High $38.79

Volume 1.22M

Average 1.10M

SNN Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Smith & Nephew plcNYSE: SNN

Gross Margin · Q4 FY2025 · quarter ended Dec 2025

Gross margin narrows to 66.1%

Gross margin was 66.1% in Q4 FY2025, down 4.5 pp from a year earlier. Over 3 fiscal years it narrowed by 2.7 pp.

Context

  • Gross margin widened in 1 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterDec 2025
66.1%— QoQ
Last fiscal yearDec 2025
68.3%-2.0 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-4.5 pp——
1 year-2.0 pp——
3 years-2.7 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
68.3%
Year-over-year change
-2.0pp

Gross Margin vs competitors

How SNN compares with its peers on the latest reported figures

  • SNN's FY2025 gross margin of 68.3% is the 5th highest of the 11 companies compared; the peer median is 65.2%.
  • Its year-over-year change of -2.0 pp is the 10th highest of 11, against a peer median of +0.3 pp.
  • Over three fiscal years its change of -2.7 pp compares with a peer median of -1.5 pp.
SNN Competitors Peer median
Gross Margin for SNN and competitors
Company Period LTM level YoY 3-year change
KIDSOrthoPediatrics Corp.LTM Mar 202673.1% +0.3 pp-1.1 pp
ZBHZimmer Biomet Holdings, Inc.LTM Jun 202669.9% -1.2 pp-9.3 pp
OFIXOrthofix Medical Inc.LTM Mar 202669.0% +1.9 pp-6.1 pp
GMEDGlobus Medical, Inc.LTM Jun 202668.5% +5.8 pp-6.8 pp
SNNSmith & Nephew plcFY202568.3% -2.0 pp-2.7 pp
ATECAlphatec Holdings, Inc.LTM Mar 202665.3% -3.6 pp+3.2 pp
SYKStryker CorporationLTM Jun 202665.2% +2.3 pp+4.1 pp
XTNTXtant Medical Holdings, Inc.LTM Mar 202662.3% +4.2 pp+7.5 pp
ENOVEnovis CorporationLTM Apr 202656.8% +0.3 pp+4.2 pp
CNMDCONMED CorporationLTM Mar 202653.6% -1.9 pp-1.9 pp
IARTIntegra LifeSciences Holdings CorporationLTM Mar 202653.2% -0.3 pp-10.6 pp
Peer median (excluding SNN) 65.2%+0.3 pp-1.5 pp

Competitors are the stored peer set for SNN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue5.21B5.22B5.55B5.81B6.16B
Cost of Revenue1.51B1.52B1.65B1.73B1.96B
Gross Profit3.7B3.7B3.9B4.08B4.21B
Gross Margin71.0%70.9%70.2%70.2%68.3%
Research & Development356M345M339M343M346M
Selling, General & Admin2.64B2.71B2.83B2.9B3.04B
Operating Expenses3.11B3.25B3.47B3.42B3.41B
Depreciation & Amortization507M492M473M449M459M
EBITDA1.22B1.15B1.21B1.34B1.34B
EBITDA Margin23.4%22.1%21.9%23.0%21.7%
Operating Income593M450M425M657M794M
Operating Margin11.4%8.6%7.7%11.3%12.9%
Interest Income6M13.99M34.13M24.01M28.07M
Interest Expense79.99M79.95M132.51M150.06M141.33M
Other Income / Expenses(7M)(215M)(135M)(159M)(15M)
Income Before Tax586M235M290M498M779M
Pre-Tax Margin11.2%4.5%5.2%8.6%12.6%
Income Tax Expense62M12M27M86M154M
Net Income524M223M263M412M625M
Net Margin10.1%4.3%4.7%7.1%10.1%
EPS (Basic)1.200.501.200.941.46
EPS (Diluted)1.200.501.200.941.44
Weighted Avg Shares438.5M437.55M217.75M438.3M433.42M
Weighted Avg Shares (Diluted)438.86M437.55M218.44M438.3M436.47M

Smith & Nephew plc

NYSE:SNN

Intrinsic Alpha fair value

Locked

Current Price

$30.32

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.